Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients

NCT01708902 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

876

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: linagliptin2.5mg/metformin1000mg
DRUG: linagliptin2.5mg/metformin1000mg
DRUG: linagliptin 5mg
DRUG: Metformin 500mg
DRUG: linagliptin2.5mg/metformin500mg
DRUG: linagliptin2.5mg/metformin500mg
DRUG: linagliptin 5mg
DRUG: Metformin 1000mg

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]